Compounds for modulating TRPV3 function

Details Compounds for modulating TRPV3 function Compounds for modulating TRPV3 function

2011-08-16

2011-08-16

Seaman, D (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S165000

Reexamination Certificate

active

07998980

ABSTRACT:
The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

REFERENCES:
patent: 4273927 (1981-06-01), White, Jr. et al.
patent: 4461896 (1984-07-01), Portluck
patent: 4509971 (1985-04-01), Forster et al.
patent: 4784682 (1988-11-01), Forster et al.
patent: 4833243 (1989-05-01), Forster et al.
patent: 5101034 (1992-03-01), Schmidt et al.
patent: 5356864 (1994-10-01), Forster et al.
patent: 5442074 (1995-08-01), Forster et al.
patent: 5990126 (1999-11-01), Park et al.
patent: 6403607 (2002-06-01), Hidaka et al.
patent: 7501446 (2009-03-01), Li et al.
patent: 2002/0156253 (2002-10-01), Curtis et al.
patent: 2003/0027164 (2003-02-01), Gaughan et al.
patent: 2003/0027232 (2003-02-01), Davis et al.
patent: 2003/0157633 (2003-08-01), Bevan et al.
patent: 2003/0219806 (2003-11-01), Glucksmann et al.
patent: 2004/0009537 (2004-01-01), Roos et al.
patent: 2005/0203159 (2005-09-01), Zelle et al.
patent: 2006/0270688 (2006-11-01), Chong et al.
patent: 2007/0179164 (2007-08-01), Chong et al.
patent: 2007/0213321 (2007-09-01), Chong et al.
patent: 3018075 (1981-11-01), None
patent: 3038599 (1982-05-01), None
patent: 3038652 (1982-05-01), None
patent: 0572893 (1993-05-01), None
patent: 0573882 (1993-06-01), None
patent: 56158702 (1981-07-01), None
patent: WO-95/01334 (1995-01-01), None
patent: WO-02/101045 (2002-12-01), None
patent: WO-2005/023242 (2005-03-01), None
patent: WO-2005/044221 (2005-05-01), None
patent: WO-2006/122156 (2006-11-01), None
Burnstock, G. and Williams, M., “P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential,” The Journal of Pharmacology and Experimental Therapeutics, 295(3):862-869 (2000).
Burnstock, Geoffrey, “Pathophysiology and Therapeutic Potential of Purinergic Signaling,” Pharmacological Reviews, 58(1):58-86 (2006).
Chung et al., “Biphasic Currents Evoked by Chemical or Thermal Activation of the Heat-gated Ion Channel, TRPV3,” J. of Biological Chemistry 280(16):15928-15941(2005).
Clapham et al., “The TRP Ion Channel Family,” Nature Reviews, 2:387-396(2001).
Clapham, David E., “Hot and Cold TRP Ion Channels,” Science, 295:2228-2229 (2002).
Clapham, David E., “TRP channels as cellular sensors,” Nature, 426:517-524 (2003).
Database Chemcats [Online], Chemical Abstracts Service, Columbus, Ohio, US; Aurora Screening Library, Order Nos. kuk-232311, ken-123216, ken-116846, Sep. 6, 2007.
Database Chemcats [Online], Chemical Abstracts Service, Columbus, Ohio, US; AKos Screening Library, Order Nos. AKL-P-1811372, AKL-P-0790097, Feb. 7, 2006.
Foresta et al., “Extracellular ATP Is a Trigger for the Acrosome Reaction in Human Spermatozoa,” J. Biol. Chem., 267(27):19443-19447 (1992).
Gopinath et al., “Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain,” BMC Women's Health, 5(2):1-9 (2005). (Also available at http://www.biomedcentral.com/1472-6874/5/2).
Moqrich et al., “Impaired Thermosensation in Mice Lacking TRPV3, a Heat and Camphor Sensor in the Skin,” Science, 307(5714):1468-1472 (2005).
Moran et al., “TRP Ion Channels in the Nervous System,” Current Opinion in Neurobiology, 14:362-369 (2004).
Peier et al., “A Heat-Sensitive TRP Channel Expressed in Keratinocytes,” Science, 296:2046-2049 (2002).
Ramsey et al., “An Introduction to TRP Channels,” Annual Rev. Physiology, 68:619-647 (2006).
RD 201017 (Research Disclosure), “Herbicidal Agents,” 201:9-17 (1981).
Smith et al., “TRPV3 is a temperature-sensitive vanilloid receptor-like protein,” Nature, 418: 186-190 (2002).
Wang et al, “Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters,” Biochemical and Biophysical Research Communications, 166(1):251-258 (1990).
Xu et al., “Oregano, thyme and clove-derived flavors and skin sensitizers activate TRP channels,” Nature Neuroscience Advance Online Publication, doi: 10.1038
n 1692, pp. 1-8 (2006).
Xu et al., “TRPV3 is a calcium-permeable temperature-sensitive cation channel,” Nature, 418: 181-186 (2002).
International Search Report from PCT/US2006/017995, mailed Nov. 22, 2006.
International Search Report from PCT/US2007/020195, mailed Jan. 28, 2008.
U.S. Appl. No. 11/431,942, filed May 9, 2006, Chong et al.
U.S. Appl. No. 11/592,783, filed Nov. 3, 2006, Chong et al.
U.S. Appl. No. 11/600,514, filed Nov. 15, 2006, Chong et al.
International Search Report and Written Opinion of the International Searching Authority for PCT/US2007/024100 issued Mar. 26, 2009.
U.S. Appl. No. 11/920,184, filed Nov. 9, 2007, Chong et al.
U.S. Appl. No. 12/084,610, filed May 5, 2008, Chong et al.
U.S. Appl. No. 12/152,131, filed May 12, 2008, Chong et al.
Banker, G.S., et al., “Modern Pharmaceutics, 3rd Ed.,” Marcel Dekker, New York, pp. 451 and 596 (1995).
Levine, J.D., et al., “TRP channels: Targets for the relief of pain,” Biochimica et Biophysica Acta, 1772:989-1003 (2007).
Vippagunta, S.R., et al., “Crystalline solids,” Advanced Drug Delivery Reviews, 48:3-26 (2001).
Wolff, M.E., “Burger's Medicinal Chemistry and Drug Discovery, 5th Ed.,” vol. 1, John Wiley & Sons, pp. 975-977 (1995).

Affiliated with

Also associated with

Rating

Compounds for modulating TRPV3 function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for modulating TRPV3 function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for modulating TRPV3 function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2742765